BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21549096)

  • 1. Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy.
    Ohsawa N; Koebis M; Suo S; Nishino I; Ishiura S
    Biochem Biophys Res Commun; 2011 May; 409(1):64-9. PubMed ID: 21549096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.
    Nakamori M; Kimura T; Fujimura H; Takahashi MP; Sakoda S
    Muscle Nerve; 2007 Aug; 36(2):251-7. PubMed ID: 17487865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.
    Savkur RS; Philips AV; Cooper TA
    Nat Genet; 2001 Sep; 29(1):40-7. PubMed ID: 11528389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1.
    Ohsawa N; Koebis M; Mitsuhashi H; Nishino I; Ishiura S
    Genes Cells; 2015 Feb; 20(2):121-34. PubMed ID: 25403273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.
    Jiang H; Mankodi A; Swanson MS; Moxley RT; Thornton CA
    Hum Mol Genet; 2004 Dec; 13(24):3079-88. PubMed ID: 15496431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
    Ho TH; Bundman D; Armstrong DL; Cooper TA
    Hum Mol Genet; 2005 Jun; 14(11):1539-47. PubMed ID: 15843400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of myotonic dystrophy type 1].
    Magaña JJ; Leyva-García N; Cisneros B
    Gac Med Mex; 2009; 145(4):331-7. PubMed ID: 20073433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
    Klein AF; Gasnier E; Furling D
    Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts.
    Machuca-Tzili L; Thorpe H; Robinson TE; Sewry C; Brook JD
    Hum Genet; 2006 Nov; 120(4):487-99. PubMed ID: 16927100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms.
    de León MB; Cisneros B
    J Neurosci Res; 2008 Jan; 86(1):18-26. PubMed ID: 17549748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on gene therapy in myotonic dystrophy type 1.
    Magaña JJ; Cisneros B
    J Neurosci Res; 2011 Mar; 89(3):275-85. PubMed ID: 21259315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ hybridization analysis of Dmpk mRNA in adult mouse tissues.
    Sarkar PS; Han J; Reddy S
    Neuromuscul Disord; 2004 Sep; 14(8-9):497-506. PubMed ID: 15336691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR.
    Storbeck CJ; Drmanic S; Daniel K; Waring JD; Jirik FR; Parry DJ; Ahmed N; Sabourin LA; Ikeda JE; Korneluk RG
    Hum Mol Genet; 2004 Mar; 13(6):589-600. PubMed ID: 14734627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
    Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
    Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
    Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G
    J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.